SCHEMBL14446367

SCHEMBL14446367

Cc1cccc(-c2ccc(F)cn2)c1

nearest known ligand 0.54

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
KDM1A O60341 1/20 0.54
IDO1 P14902 1/20 0.49
METAP2 P50579 1/20 0.49
ACHE P22303 2/20 0.45
NPC1 O15118 1/20 0.45
TP53 P04637 1/20 0.45
RAB9A P51151 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
HPGDS O60760 1/20 0.45
BCHE P06276 1/20 0.45
NR3C1 P04150 1/20 0.43
KMO O15229 2/20 0.43
PIM1 P11309 1/20 0.42
HSD17B1 P14061 1/20 0.42
HSD17B2 P37059 1/20 0.42
CYP3A4 P08684 1/20 0.42
CYP2A6 P11509 1/20 0.42
GRM5 P41594 1/20 0.42
MET P08581 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL12973163 0.83 HSD17B1 (0.59) KDM1AIDO1METAP2ACHENPC1
SCHEMBL12797772 0.83 CYP3A4 (0.59) KDM1AIDO1METAP2ACHENPC1
SCHEMBL3422110 0.81 IDO1 (0.58) KDM1AIDO1METAP2ACHENPC1
SCHEMBL4402515 0.80 HSD17B1 (0.61) KDM1AIDO1METAP2ACHEBCHE
SCHEMBL25371204 0.79 MAP4K4 (0.50) METAP2NPC1RAB9AHPGDSHSD17B1
SCHEMBL29871148 0.79 KDM1A (0.54) KDM1AIDO1METAP2ACHEBCHE
SCHEMBL30429765 0.79 MAP4K4 (0.50) METAP2NPC1RAB9AHPGDSHSD17B1
SCHEMBL30627926 0.79 KDM1A (0.54) KDM1AIDO1METAP2ACHEBCHE
SCHEMBL3878084 0.79 HSD17B1 (0.54) KDM1AIDO1METAP2ACHEBCHE
SCHEMBL15014085 0.79 KDM1A (0.54) KDM1AIDO1METAP2ACHEBCHE

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4580378-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES Universal Display Corporation (US) 2025-07-02 EP disclosed
US-20250204239-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2025-06-19 US disclosed
US-20240190906-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES UNIVERSAL DISPLAY CORPORATION (US) 2024-06-13 US disclosed
US-7250518-B2 Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes PFIZER INC. (US) 2007-07-31 US disclosed
US-7250518-B2 Nicotinamide acids, amides, and their mimetics active as inhibitors of PDE4 isozymes PFIZER INC. (US) 2007-07-31 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250204239-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES VDR, OCIAD2, OCIAD1 KDM1A 4524/4885IDO1 2124/4885METAP2 2966/4885
US-20240190906-A1 ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES VDR, OCIAD2, OCIAD1 KDM1A 4524/4885IDO1 2124/4885METAP2 2966/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.